Name: Latest research reports of Ipca Laboratories Ltd. authored by Sharekhan and published by - Trendlyne research reports.
Item: Ipca Laboratories Ltd.
Rating: 5
Author: Sharekhan

Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Mid-range Performer

1488.3000 -19.90 (-1.32%)

NSE Apr 02, 2026 15:31 PM

27.40% Gain from 52W Low

Volume: 196.4K

Ipca Laboratories Ltd.

30 Sep 2024

1488.30

-1.32%

Bayshore integration to unlock growth

Buy: Ipca Laboratories Ltd.

Target

Sharekhan

Ipca’s board would discuss the strategic integration of Bayshore Pharmaceuticals’ generics business into Unichem Pharma (USA) Inc on September 30, 2024.

Ipca Laboratories Ltd. is trading below its 30 day SMA of 1522.1